Crescita Therapeutics Inc (CTX)

Currency in CAD
0.4700
0.0000(0.00%)
Real-time Data·
CTX Scorecard
Full Analysis
Management has been aggressively buying back shares
CTX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.47000.4800
52 wk Range
0.45000.6700
Key Statistics
Bid/Ask
0.47 / 0.48
Prev. Close
0.47
Open
0.48
Day's Range
0.47-0.48
52 wk Range
0.45-0.67
Volume
4K
Average Volume (3m)
16.6K
1-Year Change
-26.56%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CTX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Crescita Therapeutics Inc Company Profile

Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. It operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The company owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers and DuraPeel that supports the development of patented formulations to facilitate the delivery of active ingredients into or through the skin. The company’s prescription products include Pliaglis, a topical local anesthetic cream that provides dermal analgesia on intact skin prior to superficial dermatological procedures; CTX-101, a Phase III topical formulation utilizing a corticosteroid in combination with MMPE technology to treat plaque psoriasis; CTX-102, a Phase I topical formulation utilizing MMPE technology to treat an undisclosed dermatological skin condition; and dermatology products in pre-clinical formulation utilizing MMPE technology for prescription treatments of skin diseases. Its non-prescription portfolio offers dermocosmetic products, such as face creams, cleansers, exfoliants, masks, serums, and suncare to treat mild acne, aging, dehydration, pigmentation, sensitivity, and rosacea under the Laboratoire Dr Renaud and Aquafolia brands; and medical aesthetics under the Pro-Derm and Alyria brands for non-invasive and minimally invasive procedures or skincare treatments. The company also distributes NCTF Boost 135 HA, a skin revitalization solution; Obagi Medical products; ART FILLER, a hyaluronic acid-based dermal filler; and MicronJet, an intradermal injection device. The company has commercialization license agreement with Cantabria Labs Inc.; and development and commercialization license agreement with Taro Pharmaceuticals Inc. Crescita Therapeutics Inc. was incorporated in 2016 and is headquartered in Laval, Canada.

0
Market
Canada

Compare CTX to Peers and Sector

Metrics to compare
CTX
Peers
Sector
Relationship
P/E Ratio
−6.7x−0.4x−0.5x
PEG Ratio
−0.120.000.00
Price/Book
0.6x0.8x2.6x
Price / LTM Sales
0.4x0.7x3.3x
Upside (Analyst Target)
-23.2%43.4%
Fair Value Upside
Unlock17.7%7.1%Unlock

Earnings

Latest Release
May 14, 2025
EPS / Forecast
-0.05 / --
Revenue / Forecast
3.54M / --
EPS Revisions
Last 90 days

CTX Income Statement

FAQ

What Stock Exchange Does Crescita Therapeutics Trade On?

Crescita Therapeutics is listed and trades on the Toronto Stock Exchange stock exchange.

What Is the Stock Symbol for Crescita Therapeutics?

The stock symbol for Crescita Therapeutics is "CTX."

What Is the Crescita Therapeutics Market Cap?

As of today, Crescita Therapeutics market cap is 8.87M.

What Is Crescita Therapeutics's Earnings Per Share (TTM)?

The Crescita Therapeutics EPS (TTM) is -0.07.

From a Technical Analysis Perspective, Is CTX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Crescita Therapeutics Stock Split?

Crescita Therapeutics has split 0 times.

How Many Employees Does Crescita Therapeutics Have?

Crescita Therapeutics has 0 employees.

What is the current trading status of Crescita Therapeutics (CTX)?

As of 08 Aug 2025, Crescita Therapeutics (CTX) is trading at a price of 0.47, with a previous close of 0.47. The stock has fluctuated within a day range of 0.47 to 0.48, while its 52-week range spans from 0.45 to 0.67.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.